Icahn School of Medicine at Mount Sinai: Breast Neoplasms trials

The registry lists 17 Breast Neoplasms studies with Icahn School of Medicine at Mount Sinai as lead sponsor. 3 are open to participants now and 3 have results posted.

Phase 1 4Phase 2 3No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Increasing Breast and Colorectal Cancer Screening in the CommunityNot yet recruitingNCT07748377Not applicable
• Enhancing Access to Supportive Services for Women of Color With Metastatic Breast CancerRecruitingNCT06405828Not applicable
• Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast CancerRecruitingNCT05095207Phase 1/2
• Increasing Breast Cancer Screening in Chinese ImmigrantsCompletedNCT05089292Not applicableResults posted
• Increasing African Immigrant Women's Participation in Breast Cancer ScreeningCompletedNCT04450264Not applicableResults posted
• Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.TerminatedNCT02936206Phase 1Results posted
• Diversity and Inclusion in Research Underpinning Prevention and Therapy TrialsCompletedNCT05146297Not applicable
• Integrated Intervention for Breast Cancer Survivors With DiabetesCompletedNCT05092477Not applicable
• Vaccination With Flt3L, Radiation, and Poly-ICLCCompletedNCT03789097Phase 1/2
• Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic BreastActive, not recruitingNCT03304080Phase 1/2
• Hypnosis to Reduce Aromatase Inhibitor Pain and Improve AdherenceCompletedNCT02657993Not applicable
• Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast CancerCompletedNCT02247037
• Comparison of Nutrition Education Alone or With Acupuncture for Weight Loss in Breast Cancer Patients Post-ChemotherapyCompletedNCT02081612Not applicable
• Tracking & Feedback Registry to Reduce Breast Cancer Treatment DisparitiesCompletedNCT01544374Not applicable
• A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6CompletedNCT00900744
• Patient Centered Randomized Controlled TrialCompletedNCT00233077Not applicable
• Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority CommunitiesCompletedNCT00145197Not applicable